Bio-Techne
TECH
#2283
Rank
NZ$13.64 B
Marketcap
NZ$87.20
Share price
4.61%
Change (1 day)
-18.58%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Earnings for Bio-Techne (TECH)

Earnings in 2025 (TTM): NZ$0.21 Billion

According to Bio-Techne's latest financial reports the company's current earnings are NZ$1.21 Billion. a decrease over its 2024 earnings that were of NZ$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bio-Techne from 1991 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.21 B-37.2%
2024 NZ$0.33 B-26.01%
2023 NZ$0.45 B-19.25%
2022 NZ$0.56 B50.77%
2021 NZ$0.37 B-1.3%
2020 NZ$0.37 B-15.46%
2019 NZ$0.44 B82.56%
2018 NZ$0.24 B11.13%
2017 NZ$0.22 B1.19%
2016 NZ$0.21 B-12.64%
2015 NZ$0.24 B-9.33%
2014 NZ$0.27 B2.19%
2013 NZ$0.26 B-1.7%
2012 NZ$0.27 B-3.5%
2011 NZ$0.28 B6.2%
2010 NZ$0.26 B-0.59%
2009 NZ$0.26 B2.78%
2008 NZ$0.26 B14.95%
2007 NZ$0.22 B15.14%
2006 NZ$0.19 B11.66%
2005 NZ$0.17 B17.05%
2004 NZ$0.15 B18.06%
2003 NZ$0.12 B26.06%
2002 NZ$0.10 B22.66%
2001 NZ$82.72 M9.92%
2000 NZ$75.25 M43.92%
1999 NZ$52.29 M31.99%
1998 NZ$39.61 M29.61%
1997 NZ$30.56 M31.62%
1996 NZ$23.22 M34.65%
1995 NZ$17.24 M16.09%
1994 NZ$14.85 M29.85%
1993 NZ$11.44 M6.35%
1992 NZ$10.75 M152%
1991 NZ$4.26 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
NZ$12.11 B 5,646.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$3.21 B 1,424.13%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$18.51 B 8,681.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$7.59 B 3,500.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$0.92 B 338.30%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-NZ$13.4 Million-106.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-NZ$1.44 Billion-782.39%๐Ÿ‡บ๐Ÿ‡ธ USA